GLP-1 Eye Injury MDL Judge Approves Early Discovery On Causation, Preemption
PHILADELPHIA — The Pennsylvania federal judge overseeing the multidistrict litigation of cases alleging that the use of glucagon-like peptide-I receptor agonist XE "glucagon-like peptide-I receptor agonist" (GLP-1 RA) medications caused permanent...To view the full article, register now.
Already a subscriber? Click here to view full article